Notably, none of the studies in patients with end-stage organ failure used activated vitamin D, indicating that the severity of kidney/heart failure may be even more important for the vitamin D-induced increase in FGF23 than the type of vitamin D (native or activated vitamin D). The gene discussed is FGF23; the disease is heart failure.